SCHEMBL7992185

SCHEMBL7992185

Cc1cccc(Cn2cnc3nc(CCN)[nH]c(=O)c32)c1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HPGD P15428 7/20 0.45
ALDH1A1 P00352 5/20 0.44
SMN1; SMN2 Q16637 4/20 0.44
KMT2A Q03164 2/20 0.44
CYP11B1 P15538 1/20 0.43
CYP11B2 P19099 1/20 0.43
HCAR2 Q8TDS4 1/20 0.42
TSHR P16473 5/20 0.42
LMNA P02545 2/20 0.42
HTT P42858 2/20 0.42
TAAR1 Q96RJ0 1/20 0.41
TP53 P04637 3/20 0.40
MEN1 O00255 1/20 0.40
HSD17B10 Q99714 1/20 0.40
ALOX15 P16050 1/20 0.39
MMP13 P45452 1/20 0.39
MAPT P10636 2/20 0.39
CYP1A2 P05177 1/20 0.38
CYP3A4 P08684 1/20 0.38
CYP2C19 P33261 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7988657 0.90 HPGD (0.45) HPGDALDH1A1SMN1; SMN2KMT2ACYP11B1
SCHEMBL7974255 0.88 HPGD (0.47) HPGDALDH1A1SMN1; SMN2KMT2ACYP11B1
SCHEMBL7988672 0.87 SMN1; SMN2 (0.47) HPGDALDH1A1SMN1; SMN2KMT2AHCAR2
SCHEMBL7988531 0.87 ALDH1A1 (0.44) HPGDALDH1A1SMN1; SMN2KMT2AHCAR2
SCHEMBL7975136 0.87 HPGD (0.45) HPGDALDH1A1SMN1; SMN2KMT2ACYP11B1
SCHEMBL7985271 0.87 GAA (0.51) HPGDALDH1A1SMN1; SMN2KMT2AHCAR2
SCHEMBL7985634 0.87 SMN1; SMN2 (0.57) HPGDALDH1A1SMN1; SMN2KMT2AHCAR2
Hydrochloric Acid SCHEMBL7987615 0.85 SMN1; SMN2 (0.56) HPGDALDH1A1SMN1; SMN2KMT2AHCAR2
SCHEMBL7988361 0.85 HPGD (0.47) HPGDALDH1A1SMN1; SMN2KMT2ACYP11B1
SCHEMBL7992187 0.83 ALDH1A1 (0.43) HPGDALDH1A1SMN1; SMN2KMT2ACYP11B1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6310070-B1 FOR TREATING NEPHRITIS, IMPROVING PROTEINURIA DUE TO GLOMERULONEPHRITIS AND PREVENTING AGGRAVATION OF NEPHRITIS JAPAN ENERGY CORPORATION (JP) 2001-10-30 US disclosed
EP-0999211-A1 NOVEL PURINE DERIVATIVES AND MEDICINAL USE THEREOF JAPAN ENERGY CORPORATION (JP) 2000-05-10 EP disclosed